Catenin-alpha1 (Phospho Ser641) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Catenin-alpha1 (Phospho Ser641) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCatenin-alpha1 (Phospho Ser641)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatimmunogen affinity purified
Size0.03 mL, 0.1 mL, 0.2 mL
Concentration1 mg/ml
ApplicationsImmunohistochemistry (IHC) Paraffin, ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Phospho-Catenin-alpha1 (S641) Polyclonal Antibody detects endogenous levels of Catenin-alpha1 protein only when phosphorylated at S641. CTNNA1 encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. Catenin alpha-1 contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy.
ImmunogenImmunogen: Synthesized peptide derived from human Catenin-alpha1 around the phosphorylation site of S641
Other Names[Rabbit Catenin-alpha1 (phospho Ser641); Catenin alpha-1; Alpha E-catenin; Cadherin-associated protein; Renal carcinoma antigen NY-REN-13]
Gene, Accession #[CTNNA1], Gene ID: 1495, NCBI: NP_001894.2, UniProt: P35221
Catalog #MBS9704531
Price$130, $220, $325
Order / More InfoCatenin-alpha1 (Phospho Ser641) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.